Sales at Rs 2.36 lakh crore, down 1 per cent; Q4 EBITDA falls 16 per cent

Syngenta Group reported a resilient financial performance for the full year 2025, delivering improved profitability and stronger margins despite a marginal decline in revenue amid a challenging global environment marked by weak commodity prices, geopolitical uncertainties and disrupted trade flows.

Full-year sales stood at Rs 2.36 lakh crore, down 1 per cent year-on-year, primarily reflecting the impact of a strategic reduction in lower-margin grain trading activities, which reduced revenue by about Rs 8,300 crore. Excluding this impact, underlying sales growth remained positive, supported by strong volume growth in Crop Protection driven by continued product innovation.

EBITDA for FY2025 rose 13 per cent to Rs 36,500 crore, and was up 17 per cent at constant exchange rates, supported by a higher-margin business mix, disciplined cost management and optimised operational efficiency. The Group’s EBITDA margin expanded by 1.9 percentage points to 15.4 per cent, reflecting improved profitability and a stronger portfolio.

In the fourth quarter of 2025, sales increased 2 per cent to Rs 63,000 crore, although they declined 1 per cent at constant exchange rates. EBITDA for the quarter fell 16 per cent to Rs 7,500 crore, impacted by restructuring costs related to the MAP transformation, higher customer credit provisions in Brazil, and a strong comparative base in Q4 2024.

Operationally, the Group delivered steady performance across business units. Crop Protection sales rose 4 per cent, supported by demand for higher-value branded formulations and innovation-led products, alongside improving channel inventory conditions, even as pricing pressure persisted in markets such as Brazil and Latin America.

The Seeds business reported sales growth of 2 per cent, driven by strong performance in Brazil, Latin America and China, supported by portfolio innovation and market share gains. The biologicals segment continued its strong momentum, recording double-digit growth, reflecting rising demand for biocontrols, biostimulants and nutrient efficiency products, supported by expanded global manufacturing capacity.

Regionally, North America led growth with strong demand trends, while Europe and Asia, Middle East and Africa recorded steady expansion. China maintained momentum despite the impact of strategic restructuring, while Latin America remained affected by pricing pressure and currency headwinds.

During the year, the Group also advanced its focus on artificial intelligence through high-impact initiatives aimed at unlocking business value and accelerating digital transformation across operations.

As part of leadership changes, Nelson Jiang was appointed Chief Financial Officer effective March 2026, while Hengde Qin transitioned to the newly created role of Chief Operating Officer, overseeing strategy execution and organisational alignment.

Overall, the FY2025 performance underscores Syngenta’s resilience and its continued focus on innovation, cost discipline and portfolio optimisation to navigate market volatility and sustain long-term growth.